Novel aspects of complement in kidney injury

Kidney International

Volumn 77, Issue 6, 2010, Pages 495-499

  Vieyra, Mark B ^a   Heeger, Peter S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Complement; Ischemia reperfusion; Kidney injury; Transplantation

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT INHIBITOR; SMALL INTERFERING RNA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; BLOOD SAMPLING; CELLULAR IMMUNITY; COMPLEMENT BLOOD LEVEL; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; KIDNEY INJURY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 77949541233     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.491     Document Type: Short Survey

References (31)

1. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582-587.
2. Medof ME, Kinoshita T, Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med 1984; 160: 1558-1578.
3. Nangaku M, Couser WG. Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol 2005; 9: 183-191.
4. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208-2214.
5. Kavanagh D, Richards A, Atkinson J. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 2008; 59: 293-309.
6. Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol 2004; 5: 981-986.
7. Farrar CA, Zhou W, Lin T et al. Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J 2006; 20: 217-226.
8. Sacks S, Zhou W. New boundaries for complement in renal disease. J Am Soc Nephrol 2008; 19: 1865-1869.
9. Pratt JR, Abe K, Miyazaki M et al. In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol 2000; 157: 825-831.
10. Lin T, Zhou W, Farrar CA et al. Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. Am J Pathol 2006; 168: 1241-1248.
11. Thurman JM, Lenderink AM, Royer PA et al. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ischemia/reperfusion. J Immunol 2007; 178: 1819-1828.
12. Zheng X, Zhang X, Feng B et al. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol 2008; 173: 973-980.
13. Lewis AG, Kohl G, Ma Q et al. Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin Exp Immunol 2008; 153: 117-126.
14. Gueler F, Rong S, Gwinner W et al. Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol 2008; 19: 2302-2312.
15. Pratt JR, Jones ME, Dong J et al. Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/ reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol 2003; 163: 1457-1465.
16. Sheerin NS, Risley P, Abe K et al. Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J 2008; 22: 1065-1072.
17. Tang Z, Lu B, Hatch E et al. C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol 2009; 20: 593-603.
18. Heeger PS, Lalli PN, Lin F et al. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005; 201: 1523-1530.
19. Lalli PN, Strainic MG, Lin F et al. Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. J Immunol 2007; 179: 5793-5802.
20. Lalli PN, Strainic MG, Yang M et al. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 2008; 112: 1759-1766.
21. Liu J, Lin F, Strainic MG et al. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol 2008; 180: 5882-5889.
22. Pavlov V, Raedler H, Yuan S et al. Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol 2008; 181: 4580-4589.
23. Raedler H, Yang M, Lalli PN et al. Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am J Transplant 2009; 9: 1784-1795.
24. Strainic MG, Liu J, Huang D et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+T cells. Immunity 2008; 28: 425-435.
25. Zhou W, Medof ME, Heeger PS et al. Graft-derived complement as a mediator of transplant injury. Curr Opin Immunol 2007; 19: 569-576.
26. Bao L, Haas M, Pippin J et al. Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest 2009; 119: 1264-1274.
27. Keslar K, Rodriguez ER, Tan CD et al. Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation 2008; 86: 1319-1321.
28. Naesens M, Li L, Ying L et al. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol 2009; 20: 1839-1851.
29. Brown KM, Kondeatis E, Vaughan RW et al. Influence of donor C3 allotype on late renal-transplantation outcome. New Engl J Med 2006; 354: 2014-2023.
30. Varagunam M, Yaqoob MM, Dohler B et al. C3 polymorphisms and allograft outcome in renal transplantation. New Engl J Med 2009; 360: 874-880.
31. Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet 2009; 373: 759-767.